ONGOING STUDIES BELLO Ballon Ellution and Late Loss Optimization study. E-BIOMATRIX A postmarket registry of the BioMatrix® Drug Eluting Stent NOBORI II A prospective, multi-center, observational study of the NOBORI™ Drug Eluting Stent system SECURITY “Second Generation” Drug-Eluting Stents Implantation followed by Six versus Twelve-Month - Dual Antiplatelet Therapy PAGES << 1.